MENU
ASND
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Ascendis Pharma A/S (ASND) Earnings Date & Reports

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

ASND is expected to report earnings to fall 111.67% to 11 cents per share on February 12

Ascendis Pharma A/S ASND Stock Earnings Reports
Q4'25
Est.
$0.12
Q3'25
Missed
by $0.72
Q2'25
Beat
by $0.45
Q1'25
Missed
by $0.11
Q4'24
Beat
by $0.34
The last earnings report on November 12 showed earnings per share of -100 cents, missing the estimate of -28 cents. With 1.91M shares outstanding, the current market capitalization sits at 12.61B.
View a ticker or compare two or three
ASND
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ASND showed earnings on November 12, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of drug candidates

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
Tuborg Boulevard 12
Phone
+45 70222244
Employees
879
Web
https://www.ascendispharma.com